Effectiveness and Safety of Nexpowder as an Endoscopic Hemostatic Treatment
Clinical trial NCT05884931 · COMPLETED
Trial details
- NCT number
- NCT05884931
- Sponsor
- Next Biomedical Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-18
- Primary completion
- 2023-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.